CBM Streamlines Cell and Gene Therapy Manufacturing Capabilities with Autolomous Digital Platform

Published on :

In its quest to be one of the top Contract Development and Manufacturing Organizations in the world, the Center for Breakthrough Medicines (CBM) will implement a robust digital solutions system that will support end-to-end cell and gene therapy manufacturing processes.